Unique

our projects

The project portfolio of Xlife Sciences AG is based on four pillars: technology platforms, biotech and therapies, medical technology and artificial intelligence. Our co-investors benefit from our unique selling proposition. In addition, our broad project portfolio offers adequate risk diversification.

Araxa Biosciences GmbH

Technology Platforms

Araxa Biosciences GmbH is a spin-off of Europe's leading life science institute, the European Molecular Biology Laboratory (EMBL) in Heidelberg. The company's goal is to further develop a technology platform that addresses the disadvantages of developing and producing AWK or RIT.

Learn more

Velabs Therapeutics GmbH

Technology Platforms

Velabs Therapeutics GmbH is a spin-off company founded by Europe’s most renowned life science research institute, the European Molecular Biology Laboratory (EMBL) and its technology transfer arm EMBLEM Technology Transfer GmbH (EMBLEM). The institute has an outstanding track record in instrument development and is a world leader in microfluidic-based screening.

Learn more

Sign up for our newsletter

We regularly report on the business development of Xlife Sciences AG and our project companies.